Literature DB >> 14561984

Are predictive factors clinically useful in bone marrow transplantation?

B J Bolwell1.   

Abstract

Variables that accurately predict the clinical outcome of any procedure, including bone marrow transplantation (BMT), are of paramount importance when assessing the risks and benefits of the procedure. This review of the world's literature of variables affecting overall outcome after myeloablative BMT critically appraises the value of many bone marrow transplant dogmas. There is a relative paucity of data supporting many commonly used transplant practices, including having an upper age limit for eligibility criteria, and absolute requirements for cardiac and pulmonary function pre transplant. In contrast, recently published literature suggests that several parameters occurring soon after a BMT has been performed may accurately predict transplant outcome. Ultimately, given the rapidly evolving nature of BMT, renewed clinical research of variables predictive of transplant outcome is needed.

Mesh:

Substances:

Year:  2003        PMID: 14561984     DOI: 10.1038/sj.bmt.1704267

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Impact of comorbidity indexes on non-relapse mortality.

Authors:  A Xhaard; R Porcher; J W Chien; R P de Latour; M Robin; P Ribaud; V Rocha; A Devergie; C Ferry; P J Martin; G Socié
Journal:  Leukemia       Date:  2008-08-07       Impact factor: 11.528

2.  Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation.

Authors:  B K Hamilton; L Rybicki; J Dabney; L McLellan; H Haddad; L Foster; D Abounader; M Kalaycio; R Sobecks; R Dean; H Duong; B T Hill; B J Bolwell; E A Copelan
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

3.  Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Authors:  Régis Peffault de Latour; Rodrigo T Calado; Marc Busson; Jeffrey Abrams; Nadir Adoui; Marie Robin; Jérôme Larghero; Nathalie Dhedin; Alienor Xhaard; Emmanuel Clave; Dominique Charron; Antoine Toubert; Pascale Loiseau; Gérard Socié; Neal S Young
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

Review 4.  Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Nonniekaye Shelburne; Margaret Bevans
Journal:  Semin Oncol Nurs       Date:  2009-05       Impact factor: 2.315

5.  Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.

Authors:  Jens M Chemnitz; Geothy Chakupurakal; Maya Bäßler; Udo Holtick; Sebastian Theurich; Alexander Shimabukuro-Vornhagen; Silke Leitzke; Michael S Von Bergwelt-Baildon; Christof Scheid
Journal:  ISRN Hematol       Date:  2014-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.